Scholars Central

Conference abstractPublished 30 Oct 2017

Management of psychosis in ParkinsonâÂ?²s disease

Authors: Susan Scanland

Dementia ConnectionÃ?Â?Ã?® LLC, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Psychosis occurs in over 50% and dementia in approximately 80% of persons with ParkinsonÃ?¢Ã?Â?Ã?Â?s disease. Treatment with non-selective atypical and typical antipsychotics significantly increases mortality rates in ParkinsonÃ?¢Ã?Â?Ã?Â?s disease; as well as other dementias. Research on the most commonly used antipsychotic in ParkinsonÃ?¢Ã?Â?Ã?Â?s, quetiapine, has not revealed significant reduction in ParkinsonÃ?¢Ã?Â?Ã?Â?s psychotic symptoms. Antipsychotic use, due to dopamine antagonism, is associated with unsteady gait and motor dysfunction; which exacerbates pre-existing Parkinsonian symptoms. Persons with ParkinsonÃ?¢Ã?Â?Ã?Â?s disease are already at risk for falls with gait asymmetry, short strides and increased stride duration. ParkinsonÃ?¢Ã?Â?Ã?Â?s patients have an increased hip fracture risk. The newly FDA-approved selective serotonin inverse agonist, pimavanserin, offers targeted treatment at the 5-HT2A receptor site responsible for ParkinsonÃ?¢Ã?Â?Ã?Â?s psychosis; without affecting dopaminergic receptor binding. Research reveals a decrease in hallucinations and delusions in ParkinsonÃ?¢Ã?Â?Ã?Â?s psychosis without worsening of motor symptoms. An evidencebased/ case study format will present management of ParkinsonÃ?¢Ã?Â?Ã?Â?s psychosis with or without dementia, using FDA-approved treatment; as opposed to antipsychotics with full black box warnings that are commonly prescribed. Clinical outcomes, costeffectiveness, quality of life, decreased risk for emergency room visits, hospitalizations and mortality and will be discussed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Susan Scanland”